Brand / product

RIFINAH

Rifampicin + Isoniazid · 300 mg + 150 mg

ShareSend this page
Official source-observed price PKR 1,280.92 32’s
PKR 40.03 / tablet
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO
This brandPKR 40.03/ tablet
Price position146% above medianvs like-for-like peer median
Peer comparators5current-price listings
🔒
MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence
View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic
Rifampicin + Isoniazid
Therapeutic area
Anti-infectives
Drug class
Antimycobacterials
ATC
J04AM
Strength
300 mg + 150 mg
Dosage form
Tablet
Pack
32’s
Registration no.
005559
Price record verified
2026-08-09
Latest DRAP source check
2026-09-23 03:18

Manufacturer

Pacific Pharmaceutical Ltd

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (32’s). Current price PKR 1,280.92, effective 1 Jul 2024.

Cite this price history

MedInfoBase. RIFINAH 300 mg + 150 mg, 32’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifinah-300-mg-150-mg-005559-32s-pacific-pharmaceutical-ltd/ (accessed 23 September 2026).

Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 1,280.922024-07-012026-08-09DRAP PharmaPrice IndexCurrent
Same generic

Other listed brands

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 005559
MedInfoBase. (2026). RIFINAH 300 mg + 150 mg Tablet (32’s), Pacific Pharmaceutical Ltd — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/rifinah-300-mg-150-mg-005559-32s-pacific-pharmaceutical-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 005559.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.